article thumbnail

12 Things You Missed at CannMed 23

Medicinal Genomics

one of just seven federally DEA- licensed cannabinoid research labs, had some encouraging news about how cannabinoids and cannaflavins can lengthen life spans while improving health spans. Watch Dr. Russo’s Presentation Hunter Land, Ph.D, the VP of Research & Development at Biopharmaceutical Research Company, Inc.,

article thumbnail

The Week in Weed: October 4, 2019

The Blunt Truth

In Connecticut , meanwhile, the state may add chronic pain to the list of conditions eligible for treatment with medical marijuana. In the world of hemp, Senator Mitch McConnell has directed the DEA to figure out how to distinguish hemp from marijuana.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Week in Weed: October 25, 2019

The Blunt Truth

The 2019 edition of the Hemp and CBD Industry Factbook released figures that show retail sales of CBD topping $1 billion this year, and predicted that number could hit $10 billion by 2024. Tourette syndrome and intractable neuropathic pain are now eligible for treatment with medical cannabis.

Hemp 58
article thumbnail

Understanding the Current Legal Status of Psychedelics in the United States

Cannabis Law Report

Food and Drug Administration (FDA) approved esketamine (a component of Ketamine and sold under the brand name Spravato) for treatment-resistant depression. The Drug Enforcement Agency (DEA) currently has guidance published for those interested in petitioning for a religious exemption to the CSA. On March 5, 2019, the U.S.

article thumbnail

Lisa’s List: Industry News Update – August 2022

Cannabis Law Report

Government Agencies seek funding to research cannabinoids as treatments for various conditions: [link]. Virginia 2024 adult use program may be postponed: [link]. DEA grants research license for psychedelics and major depression first human trial: [link]. Cannabinoids. Delta 8 now legal in Kentucky: [link].

DEA 98
article thumbnail

How to access and assess ketamine therapy options

The Cannigma

While costs to access ketamine therapy can be high in some locations, and like any drug ketamine is not a cure-all, some patients and their doctors have been reporting life-changing results when no other treatment provided relief. Patients may want to seek assistance from a certified professional prior to embarking on treatment.

Therapy 78
article thumbnail

Publicly Traded Cannabis Company Plans $500M (!) EB-5 Raise (!!)

Canna Law Blog

Drug Enforcement Administration (“DEA”), the agency tasked with enforcing the CSA. In principal at least, if the EB-5 cannabis investment is solely supplying cannabis to approved, licensed researchers pursuant to preexisting DEA approval then that is not “trafficking in an illicit substance” under the INA.

DEA 69